Resistance Oncology ApS
CVR 36945125 · Private limited company (ApS) · Active · Low risk
Resistance Oncology ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 10 annual reports have been published, of which 5 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 326k and a net result of DKK -665k. CEO: Kasper Pasternak Jørgensen, Nils Aage Brünner.
Bankruptcy risk for Resistance Oncology ApS
0.6 × the average (1.41%) · higher risk than 70% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 36945125
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (11 years)
- Address
- Amaliegade 13, 3.
1256 København K - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 51k
- Employees
- 0 (2016)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 5 of 10 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 60.8% |
| Current ratio | 101% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 6 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 52 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -411k | DKK -16k | DKK -21k |
| Net profit | DKK -665k | DKK -29k | DKK -22k |
| Equity | DKK 326k | DKK 307k | DKK -63k |
| Total assets | DKK 536k | DKK 448k | DKK 49k |
| Cash | DKK 7,015 | DKK 131k | – |
| Short-term debt | DKK 187k | DKK 140k | – |
| Avg. employees | 2 | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 184 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 197 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 187 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 192 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 179 | ||
| 1 Jan 2019 – 31 Dec 2019 | 225 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 152 | ||
| 1 Jan 2017 – 31 Dec 2017 | 157 | ||
| 1 Jul 2015 – 31 Dec 2016 | 157 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Kasper Pasternak Jørgensen | Current | |
| CEO | Nils Aage Brünner | Current | |
| CEO | Morten Fadum Nissen | ||
| CEO | Kasper Pasternak Jørgensen | ||
| CEO | Jørgen Peter Jørgensen | ||
| Owner (5%) | Alexander Meier Holding ApS | Current | |
| Owner (50%) | Pasternak Holding ApS | Current | |
| Owner (25%) | TIMPCO-RO ApS | Current | |
| Owner (5%) | Kristian Arp Regnersgaard | ||
| Owner (100%) | CORTRIS ApS | ||
| Owner (100%) | PASTERNAK JØRGENSEN HOLDING ApS | ||
| Owner (67%) | PASTERNAK JØRGENSEN HOLDING ApS | ||
| Owner (25%) | TIMPCO NB ApS | ||
| Owner (50%) | PASTERNAK JØRGENSEN HOLDING ApS | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | ANPARTSSELSKABET STAKEMANN | Current |
The CEOs' other companies
Kasper Pasternak Jørgensen – 12 other companies
- CORTRIS ApS Active
- HAMIRO HOLDING ApS Active
- JAKOB & PARTNERS ApS Active
- Linker Pharmaceuticals ApS Active
- NORDICMODERN ApS Active
- NORDICMODERN Holding ApS Active
- PASTERNAK JØRGENSEN HOLDING ApS Active
- PJ Properties ApS Active
- PJM Group ApS Active
- Pasternak Holding ApS Active
- Sample Watch ApS Active
- TPR-GROUP ApS Active
Nils Aage Brünner – 9 other companies, of which 2 bankrupt
- CYTOTRACK ApS Bankrupt 18 Jan 2022
- UDVIKLINGSSELSKABET LP AF 11. JANUAR 2001 A/S Bankrupt 2 Dec 2009
- 2cureX A/S Active
- GeneTelligence ApS Opløst
- MONOZYME ApS Compulsorily dissolved
- Scandion Oncology A/S Opløst
- TIMPCO ApS Opløst
- TIMPCO NB ApS Active
- TIMPCO-RO ApS Active
Morten Fadum Nissen – 7 other companies, of which 1 bankrupt
- HOLDINGSELSKABET AF 29. MAJ 2002 ApS Bankrupt 4 Feb 2021
- ADVOKATANPARTSSELSKABET BIRD & BIRD DANMARK Active
- ALCONCERN ApS Opløst
- CORTRIS ApS Active
- Four Birds ApS Active
- GODEED APS Compulsorily dissolved
- MFN HOLDING ApS Opløst
Jørgen Peter Jørgensen – 10 other companies
- BIRCH & COMPANY ApS Fusioneret
- CORTRIS ApS Active
- DLI - DANSK LÆGEMIDDEL INFORMATION A/S Active
- HAMIRO HOLDING ApS Active
- HILL BIRCH A/S Fusioneret
- JAKOB & PARTNERS ApS Active
- PASTERNAK JØRGENSEN HOLDING ApS Active
- PJ Properties ApS Active
- PJM Group ApS Active
- TPR-GROUP ApS Active
Address history (3 moves)
| Amaliegade 13, 3., 1256 København K | |
| Amaliegade 13, 3., 1256 København K | |
| Frederiksgade 14, 2., 1265 København K | |
| Kronprinsessegade 18, 1306 København K |
Former names
| Resistance Oncology ApS | – now |
| 3B-Oncology ApS | – |
| Cortris Nordic ApS | – |
| ApS STAKE nr. 5237 | – |
Employees per year
Other companies at the same address
- STRANDGAARD DANMARK ApS Bankrupt
- Timefly Memories IVS Bankrupt
- Alexander Meier Holding ApS Active
- Beyond Wild ApS Active
- CARL EJLER RASMUSSEN HOLDING A/S Fusioneret
- CD 12 ApS Fusioneret
- CD 5 ApS Fusioneret
- CERACO DEVELOPMENT A/S Fusioneret
- CERACO HOLDING A/S Fusioneret
- CERACO POLAND HOLDING A/S Fusioneret
- CERCO 9 ApS Fusioneret
- CORTRIS ApS Active
- EJENDOMSSELSKABET FREDERIKSBORGGADE ApS Opløst
- EJENDOMSSELSKABET BOAVISTA ApS Fusioneret
- FILM TRULY ApS Active
- HAMIRO HOLDING ApS Active
- HERSTED GRUPPEN ApS Opløst
- HPA Holding 2025 ApS Active
- Holding My Horses ApS Active
- INGRIDHUS ApS Fusioneret
- JAALCL HOLDING ApS Fusioneret
- JACOB STRUCKMANN HOLDING 2 ApS Fusioneret
- JACOB STRUCKMANN HOLDING ApS Fusioneret
- JAKOB & PARTNERS ApS Active
- JPJ Holding 2025 ApS Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about Resistance Oncology ApS
Has Resistance Oncology ApS gone bankrupt?
No, Resistance Oncology ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Resistance Oncology ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of Resistance Oncology ApS?
Kasper Pasternak Jørgensen, Nils Aage Brünner are the CEOs of Resistance Oncology ApS.
Who is the auditor of Resistance Oncology ApS?
Resistance Oncology ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Resistance Oncology ApS founded?
Resistance Oncology ApS was founded on 1 July 2015.
What is the equity of Resistance Oncology ApS?
Equity was DKK 326k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.